Benzinga | Sep 1, 2020 08:38AM EDT

Amyris Says Has 'successfully scaled up the commercial production of Cannabigerol'

EMERYVILLE, Calif., Sept. 1, 2020 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has successfully scaled up the commercial production of Cannabigerol (CBG) leveraging its industrial fermentation process capability.